Completed
Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
NCT00292864
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +3 more
- Locations
-
- Premiere Oncology of Arizona Scottsdale, Arizona, United States
- University of California Davis Medical Center Davis, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States